Glycomimetic ligands block the interaction of SARS-CoV-2 spike protein with C-type lectin co-receptors.
Chem Commun (Camb)
; 58(33): 5136-5139, 2022 Apr 21.
Article
in English
| MEDLINE | ID: covidwho-1774005
ABSTRACT
The C-type lectin receptors DC-SIGN and L-SIGN bind to glycans on the SARS-CoV-2 spike glycoprotein and promote trans-infection of ACE2-expressing cells. We tested C2 triazole-modified mono- and pseudo-di-mannosides as inhibitors of DC/L-SIGN binding to a model mannosylated protein (Man-BSA) and to SARS-CoV2 spike, finding that they inhibit the interaction of both lectins with the spike glycoprotein in a Surface Plasmon Resonance (SPR) assay and are more potent than mannose by up to 36-fold (DC-SIGN) and 10-fold (L-SIGN). The molecules described here are the first known glycomimetic ligands of L-SIGN.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Spike Glycoprotein, Coronavirus
/
COVID-19
Limits:
Humans
Language:
English
Journal:
Chem Commun (Camb)
Journal subject:
Chemistry
Year:
2022
Document Type:
Article
Affiliation country:
D2cc00121g
Similar
MEDLINE
...
LILACS
LIS